Quantcast

Concise Analysis on the International Coagulation Self-Testing Devices, Markets, Players and Prospects

February 11, 2014

DUBLIN, Feb. 11, 2014 /PRNewswire/ –

Research and Markets

(

http://www.researchandmarkets.com/research/h477tv/coagulation

) has announced the addition of the

“Concise Analysis on the International Coagulation Self-Testing Devices, Markets, Players and Prospects”

report to their offering.


(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The ability of patients to self-monitor is deemed to be a critical tool in reducing the pathological effects of difficult-to-control disease factors. For the millions of patients in the US and worldwide prescribed warfarin for oral anticoagulation therapy (OAT), the ability to monitor coagulation rates and adjust drug dosage to optimize therapeutic outcomes is a critical element of patient care. The availability of self-testing monitors provides patients with an opportunity to self-test and avoid frequent caregiver visits. Compared to blood glucose monitoring, OAT self-testing presents a higher level of complexity and risk, placing a premium on patient education.




A number of companies are now providing services to patients wishing to self-test, acting as a first-line patient resource and assisting with device selection and patient training. Wirelessly-enabled devices that allow patients to share readings with physicians electronically provide an additional safety and compliance benefit. While still a small percentage of all patients, as demographics and awareness drive increases in the diagnosed incidence of underlying conditions, patient self-testing for OAT will increasingly migrate from caregiver facilities and into homes.




Highlights


    --  Analyzes marketed patient self-testing devices for measuring and
        monitoring anticoagulation drug therapy
    --  Evaluates the status and prospects of coagulation self-test devices
        currently in development
    --  Assesses the market potential and commercialization risks and
        opportunities for coagulation self-test devices
    --  Examines the role and impact of third-party PT/INR self-test services on
        device demand and patient acceptance
    --  Provides market data and forecasts to 2018
    --  Profiles market participants, their technology, product development
        activity, and business strategies

Key Topics Covered:



Executive Summary



Anticoagulation Therapy Market Dynamics



Anticoagulation Economics

Oral Anticoagulation Therapy

Monitoring Prothrombin Time

Competing Anticoagulation Tests

Key Factors in Patient Compliance

Market Drivers

Industry Alignment and Competitive Landscape



Coagulation Self-Testing Device Design Factors



Standardization of PT/INR Testing

Accuracy and Precision

Sampling Method

Endpoint Detection

Patient/User Interface

Connectivity & Data Collection



Commercialization Factors



Managed Care and Reimbursement

Patient Training and Education

Third-Party Self-Testing Services

Market Factors

Regulations and Standards

Patient/Consumer Sentiment

Regional Demand and Demographics

Alliances and Partnerships

Proprietary Technology

Patient Self-Testing Product Assessments

CoaguChek

CoaguSense

InRatio

ProTime

Development-Stage Devices

iLine Microsystems

Microvisk

Universal Biosensors

Zin Technologies



Market Analysis, Data and Forecasts



Indications and Demographics

Therapeutic Market Segments

New Technology & Pipeline Prospects

Geographic Markets



Market Participant Profiles



For more information visit http://www.researchandmarkets.com/research/h477tv/coagulation

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets


Source: PR Newswire



comments powered by Disqus